Pulmonary Rehabilitation in Patients with Post-COVID-19 Syndrome
Keywords:
Long COVID, Long-haul COVID-19, Post-COVID-19 Syndrome, Self-pulmonary Rehabilitation, TelemedicineAbstract
The vast majority of patients infected with SARS-CoV-2 or a coronavirus that causes COVID-19 disease, especially those who have already been immunized and are in good health, have no SARS-CoV-2 virus detected within a few weeks. Those survived from the sickness may suffer from numerous organ damages during the acute period of illness. This disorder is known as "long COVID," "post-COVID-19 syndrome," or "long-haul COVID-19," which is a collection of symptoms that occur after COVID-19. This review article seeks to advise about self-pulmonary rehabilitation for survivors. The article briefly explains the pathophysiology of SARS-effects CoV-2's on the respiratory system, the pharmacology of medications used in patients with acute infections in other countries for pulmonary fibrosis and expectorants as N-acetylcysteine (NAC). Crucial pulmonary rehabilitation consists of self-pulmonary rehabilitation combined with telemedicine to reduce hospital congestion. In addition, a proper recommendation of vitamins and nutrients, including vitamin D, vitamin C, vitamin E, zinc, selenium, and omega-3 fatty acids, plays an important role in the outcome of pulmonary rehabilitation in long-term COVID patients. Telerehabilitation would assist in the verification of self-assessment and self-pulmonary rehabilitation. The patients must go to hospital to have a body checkup when abnormal symptoms are detected. Lung health is crucial towards bettering overall health.
References
Suputtitada, A., 2021, Self-Pulmonary Rehabilitation in COVID-19 Survivors and Potential Novel Therapies, A Special Talk during the Monthly Meeting of the Academy of Sciences, The Royal Society of Thailand before 75 Fellows and Associate Fellows in Multidisciplinary Areas including Medical Sciences on September 1, 2021, Published as the MP4 in the Website of King Chulalongkorn Memorial Hospital, Thai Red Cross Society and in the Website 3 of Academy of Sciences, the Royal Society of Thailand. (In Thai)
National Institute for Health and Care Excellence, 2003, COVID-19 Rapid Guideline: Managing the Long-term Effects of COVID-19 [Online], Available: https://www.ncbi.nlm.nih.gov/books/NBK11822/. [1 October 2021]
Lopez-Leon, S., Wegman-Ostrosky, T., Perelman, C., Sepulveda, R., Rebolledo, P., Cuapio, A. and Villapol, S., 2021, “More than 50 Long-term Effects of COVID-19: A Systematic Review and Meta-analysis,” Scientific Reports, 11 (1):16144. https://doi.org/10.1038/s41598-021-95565-8
Huang, C., Huang, L., Wang, Y., Li, X., Ren, L., Gu, X., Kang, L., Guo, L., Liu, M., Zhou, X., Luo, J., Huang, Z., Tu, S., Zhao, Y., Chen, L., Xu, D., Li, Y., Li, C., Peng, L., Li, Y., Xie, W., Cui, D., Shang, L., Fan, G., Xu, J., Wang, G., Wang, Y., Zhong, J., Wang, C., Wang, J., Zhang, D. and Cao, B., 2021, “6-month Consequences of COVID-19 in Patients Discharged from Hospital: a Cohort Study.” Lancet, 397, pp. 220–232. https://doi:10.1016/S0140-6736(20)32656-8
Han, X., Fan, Y., Alwalid, O., Li, N., Jia, X., Yuan, M., Li, Y., Cao, Y., Gu, J., Wu, H. and Shi, H., 2021, “Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia,” Radiology, 299 (1), pp. E177-E186. https://doi:10.1148/radiol.2021203153.
Yan, Z., Yang, M. and Lai, CL., 2021, “Long COVID-19 Syndrome: A Comprehensive Review of Its Effect on Various Organ Systems and Recommendation on Rehabilitation Plans,” Biomedicines, 9 (8), p. 966. https://doi:10.3390/biomedicines9080966.
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., Tai, Y., Bai, C., Gao, T., Song, J., Xia, P., Dong, J., Zhao, J. and Wang, FS., 2020, “Pathological Findings of COVID-19 Associated with Acute Respiratory Distress Syndrome,” The Lancet Respiratory Medicine, 8 (4), pp. 420-422. https://doi:10.1016/S2213-2600(20)30076-X
Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, MV., McGroder, C., Stevens, JS., Cook, JR., Nordvig, AS., Shalev, D., Sehrawat, TS., Ahluwalia, N., Bikdeli, B., Dietz, D., Der-Nigoghossian, C., Liyanage-Don, N., Rosner, G.F., Bernstein, E.J., Mohan, S., Beckley, A.A., Seres, DS., Choueiri, T.K., Uriel, N., Ausiello, J.C., Accili, D., Freedberg, D.E., Baldwin, M., Schwartz, A., Brodie, D., Garcia, C.K., Elkind, MSV., Connors, J.M., Bilezikian, J.P., Landry, D.W. and Wan, E.Y., 2021, “Post-acute COVID-19 Syndrome,” Nature Medicine, 27 (4), pp. 601–615. https://doi:10.1038/s41591-021-01283-z
Yong, S.J., 2021, “Long COVID or Post-COVID-19 Syndrome: Putative Pathophysiology, Risk Factors, and Treatments,” Infectious Disease, 53 (10), pp. 737-754. https://doi:10.1080/ 23744235.2021.1924397
Garg, M., Maralakunte, M., Garg, S., Dhooria, S., Sehgal, I., Bhalla, A.S., Vijayvergiya, R., Grover, S., Bhatia, V., Jagia, P., Bhalla, A., Suri, V., Goyal, M., Agarwal, R., Puri, G.D. and Sandhu, M.S., 2021, “The Conundrum of 'Long-COVID-19': A Narrative Review,” International Journal of General Medicine, 14, pp. 2491-2506. https://doi:10.2147/ijgm.s316708
Vanichkachorn, G., Newcomb, R., Cowl, C.T., Murad, M.H., Breeher, L., Miller, S., Trenary, M., Neveau, D. and Higgins, S., 2021, “Post-COVID-19 Syndrome (Long Haul Syndrome): Description of a Multidisciplinary Clinic at Mayo Clinic and Characteristics of the Initial Patient Cohort,” Mayo Clinic Proceedings, 96 (7), pp. 1782-1791. https://doi:10.1016/j.mayocp.2021.04.024
Davis, H.E., Assaf, G.S., McCorkell, L., Wei, H., Low, R.J., Re'em, Y., Redfield, S., Austin, J.P. and Akrami, A., 2021, “Characterizing long COVID in an International Cohort: 7 Months of Symptoms and their Impact,” EClinicalMedicine, 38, p. 101019. https://doi:10.1016/j.eclinm. 2021.101019.
Nielsen, K.J., Vestergaard, J.M., Schlünssen, V., Bonde, J.P., Kaspersen, K.A., Biering, K., Carstensen, O., Greve, T., Hansen, KK., Dalbøge, A., Flachs, E.M., Jespersen, S., Hansen, M.L., Mikkelsen, S., Thomsen, M.K., Redder, J.D., Würtz, E.T., Østergaard, L., Erikstrup, C. and Kolstad, H.A., 2021, “Day-by-day Symptoms following Positive and Negative PCR Tests for SARS-CoV-2 in Non-hospitalized Healthcare Workers: A 90-day follow-up study,” International Journal of Infectious Diseases, 108, pp. 382-390. https://doi:10.1016/j.ijid.2021.05.032
Vanichkachorn, G., Newcomb, R., Cowl, C.T., Murad, M.H., Breeher, L., Miller, S., Trenary, M., Neveau, D. and Higgins, S., 2021, “Post-COVID-19 Syndrome (Long Haul Syndrome): Description of a Multidisciplinary Clinic at Mayo Clinic and Characteristics of the Initial Patient Cohort,” Mayo Clinic Proceedings, 96 (7), pp. 1782-1791. https://doi:10.1016/j.mayocp.2021.04.024
Fernández-de-Las-Peñas, C., Palacios-Ceña, D., Gómez-Mayordomo, V., Florencio, L.L., Cuadrado, M.L., Plaza-Manzano, G. and Navarro-Santana, M., 2021, “Prevalence of Post-COVID-19 Symptoms in Hospitalized and Non-hospitalized COVID-19 Survivors: A Systematic Review and Meta-analysis,” European Journal of Internal Medicine, 92, pp. 55-70. https://doi:10.1016/j.ejim.2021.06.009
Chotpitayasunondh, T., Fischer, TK., Heraud, J.M., Hurt, A.C., Monto, A.S., Osterhaus, A., Shu, Y. and Tam, JS., 2021, “Influenza and COVID-19: What does Co-existence Mean?,” Influenza and Other Respiratory Viruses, 15 (3), pp. 407-412. https://doi.org/10.1111/irv.12824
Yim, J., Lim, H.H. and Kwon, Y., 2021, “COVID-19 and Pulmonary Fibrosis: Therapeutics in Clinical Trials, Repurposing, and Potential Development,” Archives of Pharmacal Research, 44 (5), pp. 499–513. https://doi:10.1007/s12272-021-01331-9
Aloufi, N., Traboulsi, H., Ding, J., Fonseca, G.J., Nair, P., Huang, S.K., Hussain, S.N.A., Eidelman, D.H. and Baglole, C.J., 2021, “Angiotensin-converting enzyme 2 expression in COPD and IPF fibroblasts: the forgotten cell in COVID-19,” American Journal of Physiology-Lung Cellular and Molecular Physiology, 320 (1), pp. L152-L157. https://doi:10.1152/ajplung.00455.2020
Sule, W.F. and Oluwayelu, D.O., 2020, “Real-time RT-PCR for COVID-19 Diagnosis: Challenges and Prospects,” The Pan African Medical Journal, 35 (Suppl 2), p. 121. https://doi:10.11604/pamj.supp.2020.35.24258
Mishra, M. and Sindhwani, G., 2021, “Antifibrotics for COVID-19 Related Lung Fibrosis: Agents with Benefits?,” Advances in Respiratory Medicine, 89 (2), pp. 231-233. https://doi:10.5603/ arm.a2021.0023
Seifirad, S., 2020, “Pirfenidone: A Novel Hypothetical Treatment for COVID-19,” Medical Hypotheses, 144, p. 110005. https://doi:10.1016/j.mehy.2020.110005
Zhang, C., Wu, Z., Li, J.W., Tan, K., Yang, W., Zhao, H. and Wang, G.Q., 2021, “Discharge may not be the End of Treatment: Pay Attention to Pulmonary Fibrosis caused by Severe COVID-19,” Journal of Medical Virology, 93 (3), pp. 1378-1386. https://doi:10.1002/jmv.26634
Vitiello, A., Pelliccia, C. and Ferrara, F., 2020, “COVID-19 Patients with Pulmonary Fibrotic Tissue: Clinical Pharmacological Rational of Antifibrotic Therapy,” SN Comprehensive Clinical Medicine, pp. 1709-1712. https://doi:10.1007/s42399-020-00487-7
Ferrara, F., Granata, G., Pelliccia, C., La Porta, R. and Vitiello, A., 2020, “The Added Value of Pirfenidone to Fight Inflammation and Fibrotic State Induced by SARS-CoV-2: Anti-inflammatory and Anti-fibrotic Therapy could Solve the Lung Complications of the Infection?,” European Journal of Clinical Pharmacology, 76 (11), pp. 1615-1618. https://doi:10.1007/s00228-020-02947-4
Artigas, L., Coma, M., Matos-Filipe, P., Aguirre-Plans, J., Farrés, J., Valls, R., Fernandez-Fuentes, N., de la Haba-Rodriguez, J., Olvera, A., Barbera, J., Morales, R., Oliva, B. and Mas, J.M., 2020, “In-silico Drug Repurposing Study Predicts the Combination of Pirfenidone and Melatonin as a Promising Candidate Therapy to Reduce SARS-CoV-2 Infection Progression and Respiratory Distress caused by Cytokine Storm,” PLoS One, 15 (10), p. e0240149. https://doi:10.1371/ journal.pone.0240149.
Serra López-Matencio, J.M., Gómez, M., Vicente-Rabaneda, E.F., González-Gay, M.A., Ancochea, J. and Castañeda, S., 2021, “Pharmacological Interactions of Nintedanib and Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Times of COVID-19 Pandemic,” Pharmaceuticals, 14 (8), p. 819. https://doi:10.3390/ph14080819
Umemura, Y., Mitsuyama, Y., Minami, K., Nishida, T., Watanabe, A., Okada, N., Yamakawa, K., Nochioka, K. and Fujimi, S., 2021, “Efficacy and Safety of Nintedanib for Pulmonary Fibrosis in Severe Pneumonia induced by COVID-19: An Interventional Study,” International Journal of Infectious Diseases, 108, pp. 454-460. https://doi:10.1016/j.ijid.2021.05.055
Zhang, Y., Lu, P., Qin, H., Zhang, Y., Sun, X., Song, X., Liu, J., Peng, H., Liu, Y., Nwafor, EO., Li, J. and Liu, Z., 2021, “Traditional Chinese Medicine Combined with Pulmonary Drug Delivery System and Idiopathic Pulmonary Fibrosis: Rationale and Therapeutic Potential,” Biomedicine and Pharmacotherapy, 133, p. 111072, https://doi:10.1016/j.biopha.2020.111072
Ogata, H., Nakagawa, T., Sakoda, S., Ishimatsu, A., Taguchi, K., Kadowaki, M., Moriwaki, A. and Yoshida, M., 2021, “Nintedanib Treatment for Pulmonary Fibrosis after Coronavirus Disease 2019,” Respirology Case Reports, 9 (5), p. e00744. https://doi:10.1002/rcr2.744
Shi, Z. and Puyo, CA., 2020, “N-Acetylcysteine to Combat COVID-19: An Evidence Review,” Therapeutics and Clinical Risk Management, 16, pp. 1047-1055. https:// doi:10.2147/tcrm.s273700
Zhou, N., Yang, X., Huang, A. and Chen, Z., 2021, “The Potential Mechanism of N-acetylcysteine in Treating COVID-19,” Current Pharmaceutical Biotechnology, 22 (12), pp. 1584-1590. https://doi:10.2174/1389201021999201228212043
de Alencar, J.C.G., Moreira, C.L., Müller, A.D., Chaves, C.E., Fukuhara, M.A., da Silva, E.A., Miyamoto, M.F.S., Pinto, V.B., Bueno, C.G., Lazar Neto, F., Gomez Gomez, L.M., Menezes, M.C.S., Marchini, J.F.M., Marino, L.O., Brandão Neto, R.A. and Souza, H.P., 2021, “COVID Register Group. Double-blind, Randomized, Placebo-controlled Trial with N-acetylcysteine for Treatment of Severe Acute Respiratory Syndrome Caused by Coronavirus Disease 2019 (COVID-19),” Clinical Infectious Diseases, 72 (11), pp. e736-e741. https://doi:10.1093/cid/ciaa1443
Luo, P., Liu, Y., Liu, D. and Li, J., 2021, “Perspectives for the Use of N-acetylcysteine as a Candidate Drug to Treat COVID-19,” Mini Reviews in Medicinal Chemistry, 21 (3), pp. 268-272. https://doi:10.2174/1389557520666201027160833
Rahimi, A., Samimagham, H.R., Azad, M.H., Hooshyar, D., Arabi, M. and KazemiJahromi, M., 2021, “The Efficacy of N-Acetylcysteine in Severe COVID-19 Patients: A Structured Summary of a Study Protocol for a Randomised Controlled Trial,” Trials, 22 (1), p. 271. https://doi:10.1186/s13063-021-05242-4
Wong, K.K., Lee, S.W.H. and Kua, K.P., 2021, “N-Acetylcysteine as Adjuvant Therapy for COVID-19 -A Perspective on the Current State of the Evidence,” Journal of Inflammation Research, 14, pp. 2993-3013, https://doi:10.2147/JIR.S306849.
Dominari, A., Hathaway Iii, D., Kapasi, A., Paul, T., Makkar, S.S., Castaneda, V., Gara, S., Singh, B.M., Agadi, K., Butt, M., Retnakumar, V., Chittajallu, S., Taugir, R., Sana, MK., Kc, M., Razzack, S., Moallem, N., Alvarez, A. and Talalaev, M., 2021, “Bottom-up Analysis of Emergent Properties of N-acetylcysteine as an Adjuvant Therapy for COVID-19,” World Journal of Virology, 10 (2), pp. 34-52. https://doi:10.5501/wjv.v10.i2.34
Avdeev, S.N., Gaynitdinova, V.V., Merzhoeva, Z.M. and Berikkhanov, Z.G., 2021, “N-acetylcysteine for the Treatment of COVID-19 among Hospitalized Patients,” The Journal of Infection, pp. S0163-4453 (21) 00329-7. https://doi:10.1016/j.jinf.2021.07.003
Mohanty, R.R., Padhy, B.M., Das, S. and Meher, B.R., 2021, “Therapeutic Potential of N-acetyl Cysteine (NAC) in Preventing Cytokine Storm in COVID-19: Review of Current Evidence,” European Review for Medical and Pharmacological Sciences, 25 (6), pp. 2802-2807. https://doi:10.26355/eurrev_202103_25442
Assimakopoulos, S.F., Aretha, D., Komninos, D., Dimitropoulou, D., Lagadinou, M., Leonidou, L., Oikonomou, I., Mouzaki, A. and Marangos, M., 2021, “N-acetyl-cysteine Reduces the Risk for Mechanical Ventilation and Mortality in Patients with COVID-19 Pneumonia: a Two-center Retrospective Cohort Study,” Infectious Diseases, 53 (11), pp. 847-854. https://doi:10.1080/ 23744235.2021.1945675
Taher, A., Lashgari, M., Sedighi, L., Rahimi-Bashar, F., Poorolajal, J. and Mehrpooya, M., 2021, “A Pilot Study on Intravenous N-Acetylcysteine Treatment in Patients with Mild-to-moderate COVID19-associated Acute Respiratory Distress Syndrome,” Pharmacological Reports, pp. 1–10. https://doi:10.1007/s43440-021-00296-2
Bauer, S.R., Kapoor, A., Rath, M. and Thomas, S.A., 2020, “What is the Role of Supplementation with Ascorbic Acid, Zinc, Vitamin D, or N-acetylcysteine for Prevention or Treatment of COVID-19?,” Cleveland Clinic Journal of Medicine, https://doi:10.3949/ccjm.87a.ccc046
Michard, F., Shelley, K. and L'Her, E., 2021, “COVID-19: Pulse Oximeters in the Spotlight,” Journal of Clinical Monitoring and Computing, 35 (1), pp. 11-14. https://doi:10.1007/s10877-020-00550-7
Medical Research Council, 2021, MRC Dyspnoea Scale/MRC Breathlessness Scale [Online], Available: https://mrc.ukri.org/research/facilities-and-resources-for-researchers/mrc-scales/mrc-dyspnoea-scale-mrc-breathlessness-scale/. [1 October 2021]
Spielmanns, M., Pekacka-Egli, A.M., Schoendorf, S., Windisch, W. and Hermann, M., 2021, “Effects of a Comprehensive Pulmonary Rehabilitation in Severe Post-COVID-19 Patients,” International Journal of Environmental Research and Public Health, 18 (5), p. 2695. https://doi:10.3390/ijerph18052695
Curci, C., Negrini, F., Ferrillo, M., Bergonzi, R., Bonacci, E., Camozzi, D.M., Ceravolo, C., Silvia, D.E.F., Guarnieri, R., Moro, P., Pisano, F. and de Sire, A., 2021, “Functional Outcome after Inpatient Rehabilitation in Postintensive Care Unit COVID-19 Patients: Findings and Clinical Implications from a Real-practice Retrospective Study,” European Journal of Physical and Rehabilitation Medicine, 57 (3), pp. 443-450. https://doi:10.23736/S1973-9087.20.06660-5
Scherr, J., Wolfarth, B., Christle, JW., Pressler, A., Wagenpfeil, S. and Halle, M., 2013, “Associations between Borg's Rating of Perceived Exertion and Physiological Measures of Exercise Intensity,” European Journal of Applied Physiology, 113 (1), pp. 147-55. https://doi:10.1007/s00421-012-2421-x
Khoramipour, K., Basereh, A., Hekmatikar, A.A., Castell, L., Ruhee, R.T. and Suzuki, K., 2021, “Physical Activity and Nutrition Guidelines to Help with the Fight Against COVID-19,” Journal of Sports Sciences, 39 (1), pp. 101-107. https://doi:10.1080/02640414.2020.1807089
Rooney, S., Webster, A. and Paul, L., 2020, “Systematic Review of Changes and Recovery in Physical Function and Fitness After Severe Acute Respiratory Syndrome-Related Coronavirus Infection: Implications for COVID-19 Rehabilitation,” Physical Therapy, 100 (10), pp. 1717-1729. https://doi:10.1093/ptj/pzaa129.
Demeco, A., Marotta, N., Barletta, M., Pino, I., Marinaro, C., Petraroli, A., Moggio, L. and Ammendolia, A., 2020, “Rehabilitation of Patients Post-COVID-19 Infection: a Literature Review,” The Journal of International Medical Research, 48(8), pp. 300060520948382. https://doi:10.1177/ 0300060520948382
Santana, A.V., Fontana, A.D. and Pitta, F., 2021, “Pulmonary Rehabilitation after COVID-19,” Journal Brasileiro de Pneumologia, 47 (1), p. e20210034. https://doi:10.36416/1806-3756/e20210034
London North West University Healthcare NHS Trust, 2020, Post Covid-19 Physiotherapy Advice and Exercise Programme [Online], Available: https://enderley.nhs.uk/wp-content/uploads/ 2020/04/Covid-booklet-post-discharge-hospital-FINAL.pdf.
Wang, T.J., Chau, B., Lui, M., Lam, G.T., Lin, N. and Humbert, S., 2020, “Physical Medicine and Rehabilitation and Pulmonary Rehabilitation for COVID-19,” American Journal of Physical Medicine and Rehabilitation, 99 (9), pp. 769-774. https://doi:10.1097/PHM. 0000000000001505
Gugnani, A., 2020, “Effects of Breathing Exercises and Incentive Spirometry in Improving Lung Capacity on Individuals with Lung Fibrosis,” European Journal of Molecular and Clinical Medicine, 7 (2), pp. 1407-1435.
Ferraro, F., Calafiore, D., Dambruoso, F., Guidarini, S. and de Sire, A., 2021, “COVID-19 related fatigue: Which role for rehabilitation in post-COVID-19 patients? A case series,” Journal of Medical Virology, 93 (4), pp. 1896–1899. https://doi:10.1002/jmv.26717
Wittmer, V.L., Paro, F.M., Duarte, H., Capellini, V.K. and Barbalho-Moulim, M.C., 2021, “Early Mobilization and Physical Exercise in Patients with COVID-19: A Narrative Literature Review,” Complementary Therapies in Clinical Practice, 43, p. 101364. https://doi:10.1016/j.ctcp.2021.101364
Funke-Chambour, M., Bridevaux, P.O., Clarenbach, C.F., Soccal, P.M., Nicod, L.P. and von Garnier, C., 2021, “Swiss Recommendations for the Follow-Up and Treatment of Pulmonary Long COVID,” Respiration, 100 (8), pp. 826-841.
Cleveland Clinic, 2018, Diaphragmatic Breathing [Online], Available: https://my. clevelandclinic. org/health/articles/9445-diaphragmatic-breathing.[1 October 2021]
Cleveland Clinic, 2018, Pursed Lip Breathing [Online], Available: https://my.clevelandclinic.org/health/articles/9443-pursed-lip-breathing. [1 October 2021]
London North West University Healthcare NHS Trust, 2020, Post Covid-19 Physiotherapy Advice and Exercise Programme [Online], Available: https://enderley.nhs.uk/wp-content/uploads/2020/04/Covid-booklet-post-discharge-hospital-FINAL.pdf. [1 October 2021]
Vassileva, D., 2020, “Is there a Place for Kinesitherapy in the Treatment of Patients with Covid-19?,” 59th Annual Scientific Conference, University of Ruse and Union of Scientists, Bulgaria, pp. 145-152.
Shakoor, H., Feehan, J., Al Dhaheri, A.S., Ali, H.I., Platat, C., Ismail, L.C., Apostolopoulos V. and Stojanovska L., 2021, “Immune-boosting Role of Vitamins D, C, E, Zinc, Selenium and Omega-3 Fatty Acids: Could they help Against COVID-19?,” Maturitas, 143, pp. 1-9. https://doi:10.1016/ j.maturitas.2020.08.003
Shah, K., Saxena, D. and Mavalankar, D., 2021, “Vitamin D Supplementation, COVID-19 and Disease Severity: a Meta-analysis,” QJM: An International Journal of Medicine, 114 (3), pp. 175-181. https://doi:10.1093/qjmed/hcab009
Liu, N., Sun, J., Wang, X., Zhang, T., Zhao, M. and Li, H., 2021, “Low Vitamin D Status is Associated with Coronavirus Disease 2019 Outcomes: a Systematic Review and Meta-analysis,” International Journal of Infectious Diseases, 104, pp. 58-64, https://doi:10.1016/j.ijid.2020.12.077
Abioye, AI., Bromage, S. and Fawzi W., 2021, “Effect of Micronutrient Supplements on Influenza and other Respiratory Tract Infections among Adults: a Systematic Review and Meta-analysis,” BMJ Global Health, 6 (1), p. e003176. https://doi:10.1136/bmjgh-2020-003176
Ghasemian, R., Shamshirian, A., Heydari, K., Malekan, M., Alizadeh-Navaei, R., Ebrahimzadeh, M.A., Ebrahimi Warkiani, M., Jafarpour, H., Razavi Bazaz, S., Rezaei Shahmirzadi, A., Khodabandeh, M., Seyfari, B., Motamedzadeh, A., Dadgostar, E., Aalinezhad, M., Sedaghat, M., Razzaghi, N., Zarandi, B., Asadi, A., Yaghoubi Naei, V., Beheshti, R., Hessami, A., Azizi, S., Mohseni, A.R. and Shamshirian, D., 2021, “The Role of Vitamin D in the Age of COVID-19: A Systematic Review and Meta-analysis,” International Journal of Clinical Practice, 75 (11), pp. e14675. https://doi:10.1111/ijcp.14675
Bassatne, A., Basbous, M., Chakhtoura, M., El Zein, O., Rahme, M. and El-Hajj Fuleihan G., 2021, “The Link between COVID-19 and Vitamin D (VIVID): A Systematic Review and Meta-analysis,” Metabolism, 119, pp. 154753. https://doi:10.1016/j.metabol.2021.154753
Teshome, A., Adane, A., Girma, B. and Mekonnen, Z.A., 2021, “The Impact of Vitamin D Level on COVID-19 Infection: Systematic Review and Meta-Analysis,” Frontiers in Public Health, 9, pp. 624559. https://doi:10.3389/fpubh.2021.624559
Rawat, D., Roy, A., Maitra, S., Shankar, V., Khanna, P. and Baidya, D.K., 2021, "Vitamin D Supplementation and COVID-19 Treatment: A Systematic Review and Meta-analysis,” Diabetes and Metabolic Syndrome, 15 (4), p. 102189. https://doi:10.1016/j.dsx.2021.102189
Petrelli, F., Luciani, A., Perego, G., Dognini, G., Colombelli, P.L.and Ghidini, A., 2021 “Therapeutic and Prognostic Role of Vitamin D for COVID-19 Infection: A Systematic Review and Meta-analysis of 43 Observational Studies,” The Journal of Steroid Biochemistry and Molecular Biology, 211, p. 105883. https://doi:10.1016/j.jsbmb.2021.105883
Griffin, G., Hewison, M., Hopkin, J., Kenny, R.A., Quinton, R., Rhodes, J., Subramanian, S. and Thickett, D., 2021, “Perspective: Vitamin D Supplementation Prevents Rickets and Acute Respiratory Infections when Given as Daily Maintenance but not as Intermittent Bolus: Implications for COVID-19,” Clinical Medicine, 21 (2), pp. e144-e149. https://doi:10.7861/clinmed.2021-0035
Oscanoa, T.J., Amado, J., Vidal, X., Laird, E., Ghashut, R.A. and Romero-Ortuno R., 2021, “The Relationship between the Severity and Mortality of SARS-CoV-2 Infection and 25-hydroxyvitamin D Concentration - a Metaanalysis,” Advances in Respiratory Medicine, 89 (2), pp. 145-157. https://doi:10.5603/ARM.a2021.0037
Corrao, S., Mallaci Bocchio, R., Lo Monaco, M., Natoli, G., Cavezzi, A., Troiani, E. and Argano, C., 2021, “Does Evidence Exist to Blunt Inflammatory Response by Nutraceutical Supplementation during COVID-19 Pandemic? An Overview of Systematic Reviews of Vitamin D, Vitamin C, Melatonin, and Zinc,” Nutrients, 13 (4), p. 1261. https://doi:10.3390/nu13041261.
The Committee and Working Group Improve the Daily Dietary Requirements for Thai People, Reference Daily Intake for Thai People, B.E. 2020, The Office of Nutrition, Department of Health, Ministry of Public Health, 2020. (In Thai)
Liu, F., Zhu, Y., Zhang, J., Li, Y. and Peng, Z., 2020, “Intravenous High-dose Vitamin C for the Treatment of Severe COVID-19: Study Protocol for a Multicentre Randomized Controlled Trial,” BMJ Open, 10 (7), p. e039519. https://doi:10.1136/bmjopen-2020-039519
Baladia, E., Pizarro, AB., Ortiz-Muñoz, L. and Rada, G., 2020, “Vitamin C for COVID-19: A Living Systematic Review,” Medwave, 20 (6), p. e7978. https://doi:10.5867/medwave.2020.06.7978
Huang, L., Wang, L., Tan, J., Liu, H. and Ni, Y., 2021, “High-dose Vitamin C Intravenous Infusion in the Treatment of Patients with COVID-19: A Protocol for Systematic Review and Meta-Analysis,” Medicine, 100 (19), p. e25876. https://doi:10.1097/MD.0000000000025876
Jamali Moghadam Siahkali, S., Zarezade, B., Koolaji, S., SeyedAlinaghi, S., Zendehdel, A., Tabarestani, M., Sekhavati Moghadam, E., Abbasian, L., Dehghan Manshadi, SA., Salehi, M., Hasannezhad, M., Ghaderkhani, S., Meidani, M., Salahshour, F., Jafari, F., Manafi, N. and Ghiasvand, F., 2021, “Safety and Effectiveness of High-dose Vitamin C in Patients with COVID-19: a Randomized Open-label Clinical Trial,” European Journal of Medical Research, 26 (1), p. 20. https://doi:10.1186/ s40001-021-00490-1.
Vollbracht, C. and Kraft, K., 2021, “Feasibility of Vitamin C in the Treatment of Post Viral Fatigue with Focus on Long COVID, Based on a Systematic Review of IV Vitamin C on Fatigue,” Nutrients, 13 (4), p. 1154. https://doi:10.3390/nu13041154
Thomas, S., Patel, D., Bittel, B., Wolski, K., Wang, Q., Kumar, A., Il'Giovine, ZJ., Mehra, R., McWilliams, C., Nissen, SE. and Desai, MY., 2021, “Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients with SARS-CoV-2 Infection: The COVID A to Z Randomized Clinical Trial,” JAMA Network Open, 4 (2), p. e210369. https://doi:10.1001/jamanetworkopen.2021.0369
Akhtar, S., Das, JK., Ismail, T., Wahid, M., Saeed, W. and Bhutta, ZA., 2021, “Nutritional Perspectives for the Prevention and Mitigation of COVID-19,” Nutrition Reviews, 79 (3), pp. 289-300. https://doi:10.1093/nutrit/nuaa063.
Doaei, S., Gholami, S., Rastgoo, S., Gholamalizadeh, M., Bourbour, F., Bagheri, SE., Samipoor, F., Akbari, ME., Shadnoush, M., Ghorat, F., Mosavi Jarrahi, SA., Ashouri Mirsadeghi, N., Hajipour, A., Joola, P., Moslem, A. and Goodarzi, M.O., “The Effect of Omega-3 Fatty Acid Supplementation on Clinical and Biochemical Parameters of Critically ill Patients with COVID-19: a Randomized Clinical Trial,” Journal of Translational Medicine, 19 (1), p. 128. https://doi:10.1186/ s12967-021-02795-5.
Brigham, E., O'Toole, J., Kim, SY., Friedman, M., Daly, L., Kaplin, A., Swarthout, M., Hasselfeld, B., Lantz-Garnish, M., Vannorsdall, T., Agranovich, A., Raju, S. and Parker, A., 2021, “The Johns Hopkins Post-Acute COVID-19 Team (PACT): A Multidisciplinary, Collaborative, Ambulatory Framework Supporting COVID-19 Survivors,” The American Journal of Medicine, 134 (4), pp. 462-467. https://doi:10.1016/j.amjmed.2020.12.009.
Sivan, D., Halpin, S. and Gee, J., 2020, Assessing Long-term Rehabilitation Needs in COVID-19 Survivors using a Telephone Screening Tool (C19-YRS Tool) [Online], Available: https://www.acnr.co.uk/wp-content/uploads/2020/06/C19-YRS-Covid-Rehab-screening-tool.pdf. [1 October 2021]
Mandal, S., Barnett, J., Brill, S.E., Brown, J.S., Denneny, E.K., Hare, S.S., Heightman, M., Hillman, T.E., Jacob, J., Jarvis, H.C., Lipman, M.C.I., Naidu, S.B., Nair, A., Porter, J.C., Tomlinson, G. S. and Hurst, J.R., 2021, “Long-COVID: A Cross-sectional Study of Persisting Symptoms, Biomarker and Imaging Abnormalities following Hospitalisation for COVID-19,” Thorax, 76 (4), pp. 396–398. https://doi:10.1136/thoraxjnl-2020-215818.
Notification of the Ministry of Public Health Re: Standards for Hospital Services Using the Telemedicine Service System B.E. 2021, Government Gazette, February 1, 2021, Volume 138, Special Section 23 D, p. 6. (In Thai)
Announcement of the Medical Council of Thailand No. 54/2563 Regarding the Practice Guidelines for Telemedicine or Telemedicine (Telemedicine) and Online Clinic, July 9, 2021. (In Thai)
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 King Mongkut's University of Technology Thonburi
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Any form of contents contained in an article published in Science and Engineering Connect, including text, equations, formula, tables, figures and other forms of illustrations are copyrights of King Mongkut's University of Technology Thonburi. Reproduction of these contents in any format for commercial purpose requires a prior written consent of the Editor of the Journal.
